Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of Waterloo

$33,000.00

Integration of strain engineering with bioprocess engineering strategies to enhance biobased production of value-added chemicals

FY 2020-21

Summary
To date, most chemical products are still made via chemical processing with fossil fuels as raw materials, not only depleting fossil fuels but also generating significant amounts of greenhouse gases (GHGs). Hence, replacing chemical production with modern biobased production potentially offers a true solution to both GHG mitigation and sustainable manufacturing, realizing "low carbon" economy. The proposed research will target biotechnological development of novel engineered bacterial Escherichia coli strains and their associated bioprocessing strategies for clean, effective, economical, renewable, and sustainable production of value-added chemicals. Recently, we successfully demonstrated heterologous production of non-native 1-propanol and propionate in engineered E. coli through activation of a natural sleeping beauty mutase (Sbm) pathway. An important implication associated with our demonstration is that activation of the Sbm pathway introduces a C3-fermentative pathway with the formation of a non-native metabolite intermediate propionyl-CoA in E. coli. The presence of propionyl-CoA opens a wide avenue for novel bacterial synthesis of a selection of non-native high-value bioproducts from unrelated carbon sources using E. coli as a cell factory. In this proposed research, two valuable bioproducts derived from propionyl-CoA, i.e. 3-hydroxyvalerate (3-HV) and valerate, will be used for technological demonstration. First, we will apply various state-of-the-art microbial biotechnologies, including synthetic biology, genetic/genomic engineering, protein engineering, and metabolic engineering to further engineer these propanologenic (propanol-producing) E. coli strains for heterologous production of 3-HV and valerate. Additionally, we will explore these engineered bacterial strains for effective biotransformation using cheap feedstocks, including glycerol, lignocelluloses, and volatile fatty acids. Finally, we will characterize and optimize operating conditions and bioprocessing strategies for large-scale production and evaluate the economic feasibility of developed bioprocesses. It is anticipated that the success of the proposed research in developing effective biobased production platforms will mediate scientific and engineering advances in biomanufacturing, enhance economic feasibility of bioprocessing, and alleviate major environmental impacts caused by traditional chemical processing. The engineered bacterial strains and developed bioprocesses can be readily transferred to our Canadian industrial partners for commercialization, boosting Canada's technological leadership in biomanufacturing. In addition, the proposed research is highly multidisciplinary as its technological aspects cover both fundamental biological sciences and practical biochemical engineering applications; and therefore will be ideal for training of highly qualified personnel (HQP) meeting the challenges of the next generation of industrial biotechnology.
Program
Discovery Grants Program - Individual
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2019-04611
Name nom
Chou, Perry
Department département
Chemical Engineering
Organization id
33
Institution établissement
University of Waterloo
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2019
Award amount
33000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1511
Committee name en
Materials and Chemical Engineering
Committee name fr
Génie chimique et des matériaux
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
1802
Research subject group en
Chemical engineering
Research subject group fr
Génie chimique
Research subject en
Biochemical engineering
Research subject fr
Génie biochimique
Installment
inst:2-5
Partie
4
Nb partie
5
Application title
Integration of strain engineering with bioprocess engineering strategies to enhance biobased production of value-added chemicals
Keyword
NSERC
Application summary
To date, most chemical products are still made via chemical processing with fossil fuels as raw materials, not only depleting fossil fuels but also generating significant amounts of greenhouse gases (GHGs). Hence, replacing chemical production with modern biobased production potentially offers a true solution to both GHG mitigation and sustainable manufacturing, realizing "low carbon" economy. The proposed research will target biotechnological development of novel engineered bacterial Escherichia coli strains and their associated bioprocessing strategies for clean, effective, economical, renewable, and sustainable production of value-added chemicals. Recently, we successfully demonstrated heterologous production of non-native 1-propanol and propionate in engineered E. coli through activation of a natural sleeping beauty mutase (Sbm) pathway. An important implication associated with our demonstration is that activation of the Sbm pathway introduces a C3-fermentative pathway with the formation of a non-native metabolite intermediate propionyl-CoA in E. coli. The presence of propionyl-CoA opens a wide avenue for novel bacterial synthesis of a selection of non-native high-value bioproducts from unrelated carbon sources using E. coli as a cell factory. In this proposed research, two valuable bioproducts derived from propionyl-CoA, i.e. 3-hydroxyvalerate (3-HV) and valerate, will be used for technological demonstration. First, we will apply various state-of-the-art microbial biotechnologies, including synthetic biology, genetic/genomic engineering, protein engineering, and metabolic engineering to further engineer these propanologenic (propanol-producing) E. coli strains for heterologous production of 3-HV and valerate. Additionally, we will explore these engineered bacterial strains for effective biotransformation using cheap feedstocks, including glycerol, lignocelluloses, and volatile fatty acids. Finally, we will characterize and optimize operating conditions and bioprocessing strategies for large-scale production and evaluate the economic feasibility of developed bioprocesses. It is anticipated that the success of the proposed research in developing effective biobased production platforms will mediate scientific and engineering advances in biomanufacturing, enhance economic feasibility of bioprocessing, and alleviate major environmental impacts caused by traditional chemical processing. The engineered bacterial strains and developed bioprocesses can be readily transferred to our Canadian industrial partners for commercialization, boosting Canada's technological leadership in biomanufacturing. In addition, the proposed research is highly multidisciplinary as its technological aspects cover both fundamental biological sciences and practical biochemical engineering applications; and therefore will be ideal for training of highly qualified personnel (HQP) meeting the challenges of the next generation of industrial biotechnology.